ClinicalTrials.Veeva

Menu

Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

H

Hvidovre University Hospital

Status

Completed

Conditions

Healthy Subjects

Treatments

Other: Incretin hormone - Glucose-dependent insulinotropic polypeptide (GIP)

Study type

Observational

Funder types

Other

Identifiers

NCT00999271
HD-2009-0025

Details and patient eligibility

About

The aim of this proposal is to examine whether endogenous GIP and exogenous GIP alone and in combination with insulin affect gastric emptying (GE), appetite, energy intake, energy expenditure (EE) and plasma levels of triglycerides (TAG), free fatty acids FFA) and glycerol in man.

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Informed oral and written consent
  • Caucasians over the age of 18 years
  • Normal 75 g oral glucose tolerance test (OGTT)
  • Normal blood haemoglobin concentration
  • Normal plasma lipid profile

Exclusion criteria

  • First-degree relatives with diabetes and familial hypertriglyceridemia

Trial design

30 participants in 1 patient group

Healthy subjects
Description:
30 healthy subjects without family history of diabetes or gastrointestinal disease, a normal oral glucose tolerance test (OGTT) and no intake of medicine
Treatment:
Other: Incretin hormone - Glucose-dependent insulinotropic polypeptide (GIP)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems